Meeting
2022 ASCO Gastrointestinal Cancers Symposium
REGINA: A phase II trial of neoadjuvant regorafenib (Rego) in combination with nivolumab (Nivo) and short-course radiotherapy (SCRT) in intermediate-risk, stage II-III rectal cancer (RC).
Authors
Giacomo Bregni
Institut Jules Bordet-Université Libre de Bruxelles (ULB), Brussels, Belgium
Giacomo Bregni , Chiara Senti , Elena Acedo Reina , Paraskevas Gkolfakis , Luigi Moretti , Ana Veron , Pieter Demetter , Gabriel Liberale , Javier Carrasco , Karen Paula Geboes , Yeter Gokburun , Marc Peeters , Marc Van Den Eynde , Jean-Luc Van Laethem , Philippe Vergauwe , Marc E. Buyse , Amélie Deleporte , Alain Hendlisz , Francesco Sclafani
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
NCT04503694
DOI
10.1200/JCO.2022.40.4_suppl.TPS226
Abstract #
TPS226
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
EA2201: An ECOG-ACRIN phase II study of neoadjuvant nivolumab plus ipilimumab and short course radiation in MSI-H/dMMR rectal tumors.
First Author: Kristen Keon Ciombor
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Total neoadjuvant therapy (TnT) with FOLFOX followed by short course radiation in locally advanced rectal cancer: A phase II study.
First Author: Janice Zhao
Poster
2023 ASCO Annual Meeting
Predictive value of tumor-infiltrating lymphocyte (TIL) dynamics in the tumor microenvironment (TME) during preoperative chemoradiotherapy (CRT) on pathologic complete response (pCR) in microsatellite-stable (MSS) locally advanced rectal cancer (LARC).
First Author: Mitsuho Imai
Poster
2022 ASCO Annual Meeting
Preoperative chemoradiotherapy with capecitabine with or without temozolomide in patients with locally advanced rectal cancer: A prospective, randomized phase 2 study stratified by MGMT (O6-methylguanine DNA methyltransferase) status: KCSG-CO17-02.
First Author: Chung Ryul Oh